Abiopharma

Director MATLIN DAVID J 🟢 acquired 33.3K shares (2 derivative) of Clene Inc. (CLNN) at $6.50 Transaction Date: Jan 13, 2026 | Filing ID: 001170

📋 Finn Patrick John (Officer) plans to sell 23K shares of Twist Bioscience Corp (at $40.00 each, total $931K) Filed: Jan 13, 2026 | ID: 000275

📋 Laponis Adam (Officer) plans to sell 3K shares of Twist Bioscience Corp (at $40.00 each, total $120K) Filed: Jan 13, 2026 | ID: 000274

New Form SCHEDULE 13G - GridAI Technologies Corp. Filed: 2026-01-13 AccNo: 0001213900-26-003817 Size: 14 KB

📋 MIKKELSEN JAN MOLLER (Officer) plans to sell 87K shares of Ascendis Pharma A/S (at $211.99 each, total $18.4M) Filed: Jan 13, 2026 | ID: 000011

Travere Therapeutics Announces FDA Extends Review of sNDA for FILSPARI® (sparsentan) in FSGS

New Form 6-K/A - Inspira Technologies OXY B.H.N. Ltd Filed: 2026-01-13 AccNo: 0001213900-26-003780 Size: 124 KB

(99% Neutral) Virios Therapeutics Inc. (VIRI) Provides Update on investor for up to approximately $12

(99% Neutral) Co-Diagnostics Inc (CODX) Files Form 8-K

New Form 8-A12B - BriaCell Therapeutics Corp. Filed: 2026-01-13 AccNo: 0001493152-26-001969 Size: 401 KB

New Form 424B5 - Dogwood Therapeutics, Inc. Filed: 2026-01-13 AccNo: 0001104659-26-003197 Size: 401 KB

Law Offices of Frank R. Cruz Encourages agilon health, inc. (AGL) Shareholders To Inquire About Securities Fraud Class Action

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

Attalon Launches as Independent Defense Technology Leader; Appoints John Bergeron as CEO to Strengthen Leadership in Precision Optics and Directed Energy

Perrigo Company plc (PRGO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit